Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Gerino Launch First Time in the World DIFI Currency Business
  • EO Noida Adds Another Feather to Its Cap: Celebrating the Rockstar Platinum Award 2023-24 Business
  • Thapar Gallery Opens its Doors to ‘Celebrating the Modernists of Indian Art’ Inbox Lifestyle
  • Global Leaders in Infertility Management, ART Fertility Clinics launches Festival bonanza, Get Lucky Draw on IVF Treatment Health
  • 100xdevs – a new developer training school is changing the game Education
  • Flamingo Transworld launches tours to some of the finest destinations to explore in 2024 National
  • Kingston Technology Is with India’s Fight against COVID-19 Business
  • Entrepreneur Sahil Narang Expands His Empire with the Launch of Amigo Holiday Homes and Amigo Car Rental Business

Optimus Pharma launched a new Anti-Parkinson’s Drug in India

Posted on April 26, 2021 By

Hyderabad (Telangana) [India], April 26: Optimus Pharma has announced today that it has received DCGI approval for its Anti-Parkinson’s drug Safinamide. Safinamide is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes.

The burdens of Parkinson’s Disease (PD) are undeniably serious and increasing while various unmet needs remain, especially the absence of disease-modifying therapies, especially in Indian Market. Optimus believes Safinamide will give an additional option to healthcare professionals in the treatment of Parkinson’s and improve the quality of life of millions who are affected by Parkinson’s disease. A homegrown generic version of Safinamide developed by Optimus will assist in delivering robust treatment for Parkinson’s diseases in India with very high affordability and accessibility.

About Parkinson’s Disease

Parkinson’s disease (PD) is one of the most common neurologic disorders, affecting approximately 1% of individuals older than 60 years and causing progressive disability that can be slowed but not halted, by treatment. Parkinson’s disease is a movement disorder that causes involuntary movements and rigidity, as well as abnormal walking and posture. It is caused by an imbalance between two chemicals that transmit signals from the brain, dopamine, and acetylcholine.

Disclaimer:

Statements in this “Document” describing the Company’s objectives, projections, estimates, expectations, plans or predictions, or industry conditions or events may be “forward-looking statements” within the meaning of applicable securities laws and regulations. Actual results, performance, or achievements could differ materially from those expressed or implied. The Company undertakes no obligation to update or revise forward-looking statements to reflect developments or circumstances that arise or to reflect the occurrence of unanticipated developments/circumstances after the date hereof.

Business, English, Health Tags:Anti-ParkinsonDrug, OptimusPharma, PNN

Post navigation

Previous Post: Marg Mart: A Life-Saver in the Age of Covid-19
Next Post: Dr. Amit Kamle revolutionises Gospel Music through his soulful melodies

Related Posts

  • Keeping Your Liver Healthy and Disease Free, Observing World Liver Day 2024 Health
  • Watanabe Business Quiz, with participation from over 50 B Schools, to be held at Mumbai on 25 – 26 February 2023 Business
  • The untapped GOLD mine of UK INDIA FREE TRADE AGREEMENT Business
  • SatisComm (India) Pvt. Ltd. – Sales & Distribution Accelerator for Emerging Brands in the Global Market Business
  • CKKA: The Best Marketing Tool Empowering Local Entrepreneurs and Fueling Community Growth Business
  • Rakuten Symphony agrees to acquire leading US-based cloud technology company Robin.io to deliver highly integrated telco-cloud for mobile Business

Recent Posts

  • Gracias Living Launches Emotion-Responsive Dementia Care Unit in Gurgaon
  • India’s Development March: From Spiritual Roots to Strategic Tech! A Unified Vision for a Viksit Bharat
  • National Conference on Unity for Growth – A Collective March Towards Viksit Bharat
  • Sri Shankari Yoga Institute Marks 13 Years with International Yoga Day And New World Record Celebration
  • Shaping the Future: The 2025 Indian Business Excellence Award Winners

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Entrepreneur Launched A Golden Idea in the Quick Service Restaurant Industry: Deepak Barge Business
  • Focus Lighting H1 FY23 EBITDA up by 638% Business
  • Refueling your potential with NeenOpal Business
  • Maharashtra observes Fire Service Week to increase awareness on fire safety and evacuation measures Business
  • Rising Phishing Scams Targeting the Indian Electric Vehicle Industry Business
  • La Excellence IAS Academy Achieves Remarkable Success in UPSC Civil Services Exam 2022 Press Release
  • Grippon Embraces JSW steel Innovations with launch of Magsure for Future Steel Structures Business
  • Inspiring Minds, Conquering Words: Mind Wars Spell Bee 2023 Unveils Its Champions! Education

Copyright © 2025 Daily News India.

Powered by PressBook News WordPress theme